Physician
Montefiore Medical Center
Montefiore Medical Center was paid $398.40M by Medicaid between Jan 2018 and Dec 2024, across 710 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoMONTEFIORE MEDICAL CENTER
BRONX, NY 10467
BRONX, NY 10467
33aNPI1063525152assigned 08/16/2006
33bProvider typeOrthopaedic Surgery Physician
28Total paid$398.40M
24GClaims6,356,829
24DCodes billed710
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Orthopaedic Surgery Physician providers in New York
Rank by total paid#1 of 429
Median peer was paid$4K
This provider vs. median103,666×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 684,262 | $44.01M | |
| 2019 | 796,563 | $50.21M | |
| 2020 | 679,938 | $43.79M | |
| 2021 | 1,069,585 | $62.90M | |
| 2022 | 1,081,408 | $71.70M | |
| 2023 | 1,160,693 | $70.74M | |
| 2024incomplete | 884,380 | $55.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 586,031 | 560,498 | $61.54M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 788,434 | 748,014 | $60.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.2% | 197,487 | 194,164 | $24.74M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.0% | 104,761 | 104,012 | $15.83M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.8% | 154,298 | 151,876 | $11.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.8% | 63,567 | 62,050 | $10.96M |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 2.6% | 6,402 | 6,375 | $10.43M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 99,234 | 98,681 | $10.37M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 64,570 | 60,356 | $8.49M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.8% | 72,136 | 26,878 | $7.08M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 74,656 | 73,463 | $6.07M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 71,704 | 71,314 | $5.82M |
698 more codes
| 99232 | Hospital visit by a doctor, follow-up day | 1.4% | 78,722 | $5.38M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 62,169 | $5.37M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 61,906 | $5.02M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.1% | 19,071 | $4.35M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.0% | 32,766 | $4.10M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 57,612 | $3.90M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 41,858 | $3.87M |
| 99223 | Prolong inpt eval add15 m | <1% | 21,896 | $3.51M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 119,854 | $3.49M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 55,086 | $3.49M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 31,511 | $3.31M |
| 96127 | <1% | 332,139 | $3.29M | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 14,799 | $3.22M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 83,724 | $2.65M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 50,334 | $2.61M |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 29,548 | $2.53M |
| 20610 | <1% | 43,134 | $2.50M | |
| 76830 | Ultrasound, transvaginal | <1% | 23,359 | $2.33M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 15,303 | $2.21M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 65,193 | $2.17M |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 17,279 | $2.10M |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 48,188 | $1.97M |
| 71046 | Radiologic examination, chest; 2 views | <1% | 153,290 | $1.92M |
| 99205 | Prolong outpt/office vis | <1% | 10,372 | $1.85M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 43,800 | $1.69M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 8,455 | $1.68M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 17,533 | $1.64M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 1,078 | $1.56M |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 68,599 | $1.54M |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 21,518 | $1.47M |
| 92551 | <1% | 101,956 | $1.47M | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 197,555 | $1.46M |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 1,068 | $1.43M |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 19,751 | $1.38M |
| 71045 | Radiologic examination, chest; single view | <1% | 147,278 | $1.34M |
| 76801 | <1% | 9,958 | $1.32M | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 10,336 | $1.28M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 11,522 | $1.20M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 25,223 | $1.20M |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 7,507 | $1.19M |
| 99442 | <1% | 17,274 | $1.19M | |
| 76818 | <1% | 17,573 | $1.14M | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 46,776 | $1.14M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 7,443 | $1.14M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 54,564 | $1.12M |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 7,589 | $1.10M |
| 93970 | <1% | 24,796 | $1.09M | |
| 99443 | <1% | 10,403 | $1.07M | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 101,731 | $1.07M |
| 76857 | <1% | 21,577 | $1.01M | |
| 31231 | <1% | 7,793 | $995K | |
| 00731 | <1% | 4,303 | $922K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 6,439 | $912K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 9,926 | $909K |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 1,906 | $867K |
| 76770 | <1% | 21,752 | $860K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 6,110 | $857K |
| 76813 | <1% | 5,995 | $845K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 4,633 | $835K |
| 93000 | <1% | 46,178 | $789K | |
| 73562 | <1% | 26,344 | $782K | |
| 88141 | <1% | 28,660 | $780K | |
| 99460 | <1% | 8,352 | $776K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,979 | $776K |
| 88307 | <1% | 6,605 | $769K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 11,128 | $755K |
| 99221 | <1% | 8,087 | $748K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 23,891 | $738K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 14,632 | $734K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 7,735 | $672K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 7,657 | $665K |
| 43775 | <1% | 492 | $656K | |
| 88342 | <1% | 11,018 | $641K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 18,962 | $631K |
| 76825 | <1% | 2,227 | $608K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 9,701 | $603K |
| 73630 | <1% | 27,134 | $545K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 4,401 | $544K |
| 87536 | <1% | 5,476 | $529K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 5,386 | $506K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 11,451 | $493K |
| 71250 | <1% | 9,241 | $465K | |
| 76642 | <1% | 10,870 | $464K | |
| 77014 | <1% | 10,684 | $456K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 7,386 | $454K |
| 74183 | <1% | 2,147 | $451K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 1,850 | $418K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 581 | $379K |
| 90686 | <1% | 82,530 | $377K | |
| 77062 | <1% | 2,430 | $373K | |
| 46607 | <1% | 1,304 | $343K | |
| 77066 | Tomosynthesis, mammo | <1% | 5,241 | $335K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,149 | $312K |
| 93976 | <1% | 4,673 | $305K | |
| 92557 | <1% | 9,024 | $298K | |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | <1% | 685 | $297K |
| 73610 | <1% | 14,802 | $284K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 518 | $279K |
| 95720 | <1% | 1,359 | $279K | |
| 77065 | Tomosynthesis, mammo | <1% | 5,788 | $275K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 825 | $275K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,450 | $273K |
| 73030 | <1% | 13,678 | $271K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,272 | $265K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 550 | $260K |
| 64615 | <1% | 1,684 | $258K | |
| 76641 | <1% | 3,808 | $256K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 5,387 | $256K |
| 54150 | <1% | 2,457 | $256K | |
| 84165 | <1% | 17,406 | $253K | |
| 00142 | <1% | 2,543 | $251K | |
| 92134 | <1% | 9,552 | $249K | |
| 99462 | <1% | 5,857 | $246K | |
| 74018 | <1% | 23,853 | $238K | |
| H0049 | Alcohol and/or drug screening | <1% | 12,314 | $237K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 4,010 | $236K |
| 86360 | <1% | 4,720 | $232K | |
| 97161 | <1% | 2,959 | $232K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,420 | $231K |
| 72082 | <1% | 5,059 | $228K | |
| 92567 | <1% | 16,103 | $227K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 5,875 | $220K |
| 36415 | Collection of venous blood by venipuncture | <1% | 59,110 | $219K |
| 76536 | <1% | 5,179 | $218K | |
| 76821 | <1% | 2,096 | $218K | |
| 76820 | <1% | 4,288 | $217K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,636 | $214K |
| 93320 | <1% | 10,843 | $212K | |
| 99385 | <1% | 1,765 | $206K | |
| 72141 | <1% | 1,646 | $204K | |
| 31575 | <1% | 2,225 | $203K | |
| 88304 | <1% | 14,601 | $201K | |
| 86359 | <1% | 4,727 | $201K | |
| 99292 | <1% | 1,494 | $199K | |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 1,409 | $197K |
| 97802 | <1% | 3,008 | $189K | |
| 99441 | <1% | 3,890 | $188K | |
| 73221 | <1% | 1,634 | $186K | |
| 85390 | <1% | 6,202 | $186K | |
| 58340 | <1% | 616 | $185K | |
| 97803 | <1% | 3,146 | $185K | |
| 93297 | <1% | 10,992 | $183K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,759 | $182K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 25,718 | $181K |
| 90671 | <1% | 1,073 | $178K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,438 | $177K |
| 95951 | <1% | 504 | $174K | |
| 92083 | <1% | 4,778 | $171K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,665 | $169K |
| 76827 | <1% | 2,188 | $169K | |
| 00812 | <1% | 1,060 | $168K | |
| 72100 | <1% | 9,262 | $165K | |
| 76942 | <1% | 5,950 | $164K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 12,966 | $160K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 1,216 | $154K |
| 20550 | <1% | 3,059 | $154K | |
| 88341 | <1% | 1,190 | $152K | |
| 93325 | <1% | 17,240 | $152K | |
| 73130 | <1% | 10,267 | $150K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,198 | $149K |
| 76376 | <1% | 3,136 | $149K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 770 | $145K |
| 93015 | <1% | 2,086 | $143K | |
| 95117 | <1% | 11,249 | $141K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,920 | $139K |
| 73110 | <1% | 6,583 | $139K | |
| 00790 | <1% | 230 | $137K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,357 | $130K |
| 92015 | Determination of refractive state | <1% | 7,810 | $130K |
| 99072 | <1% | 116,325 | $128K | |
| 95816 | <1% | 2,034 | $127K | |
| 92133 | <1% | 5,409 | $127K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,829 | $122K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,908 | $120K |
| 88112 | <1% | 2,212 | $117K | |
| 54161 | <1% | 526 | $114K | |
| 00811 | <1% | 730 | $113K | |
| 76506 | <1% | 3,064 | $110K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,574 | $110K |
| 96156 | <1% | 1,122 | $110K | |
| 95782 | <1% | 829 | $109K | |
| 59514 | <1% | 80 | $107K | |
| 73560 | <1% | 7,770 | $106K | |
| 77061 | <1% | 989 | $106K | |
| 70544 | <1% | 1,256 | $103K | |
| 99451 | <1% | 2,595 | $97K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 481 | $95K |
| 86480 | <1% | 1,365 | $94K | |
| 77427 | <1% | 487 | $93K | |
| 64400 | <1% | 1,074 | $90K | |
| 94010 | <1% | 6,473 | $89K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 912 | $88K |
| 76831 | <1% | 552 | $88K | |
| 80053 | Comprehensive metabolic panel | <1% | 6,560 | $87K |
| 78306 | <1% | 505 | $86K | |
| 31579 | <1% | 576 | $85K | |
| 0071A | <1% | 2,042 | $85K | |
| 01961 | <1% | 117 | $84K | |
| 93880 | <1% | 1,399 | $84K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 787 | $84K |
| 00840 | <1% | 134 | $82K | |
| 93295 | <1% | 2,589 | $81K | |
| 11900 | <1% | 1,399 | $81K | |
| 97804 | <1% | 3,616 | $80K | |
| 93971 | <1% | 3,034 | $79K | |
| 93298 | <1% | 3,956 | $78K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 3,168 | $78K |
| 99464 | <1% | 1,087 | $78K | |
| 64450 | <1% | 2,112 | $78K | |
| 96167 | <1% | 1,415 | $76K | |
| 99254 | <1% | 443 | $76K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 566 | $74K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 819 | $74K |
| 81002 | <1% | 25,797 | $74K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 497 | $74K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 824 | $73K |
| 88291 | <1% | 2,375 | $73K | |
| 46600 | <1% | 773 | $73K | |
| 25600 | <1% | 168 | $71K | |
| 90651 | <1% | 2,023 | $71K | |
| 93925 | <1% | 1,914 | $71K | |
| 99381 | <1% | 851 | $71K | |
| 11901 | <1% | 1,017 | $70K | |
| 88189 | <1% | 909 | $70K | |
| 73502 | <1% | 3,225 | $70K | |
| 70486 | <1% | 1,386 | $69K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,149 | $68K |
| 99459 | <1% | 2,924 | $67K | |
| 75574 | <1% | 604 | $66K | |
| 83020 | <1% | 3,719 | $66K | |
| 20611 | <1% | 775 | $65K | |
| 78582 | <1% | 1,062 | $64K | |
| 93923 | <1% | 2,075 | $63K | |
| 93886 | <1% | 814 | $63K | |
| 11721 | <1% | 2,508 | $61K | |
| 93016 | <1% | 3,248 | $61K | |
| 96154 | <1% | 2,082 | $61K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,638 | $59K |
| 27447 | <1% | 50 | $59K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 1,114 | $59K |
| 93308 | <1% | 2,623 | $58K | |
| 00797 | <1% | 118 | $58K | |
| 90715 | <1% | 1,598 | $58K | |
| 88108 | <1% | 2,624 | $58K | |
| 59025 | Fetal non-stress test | <1% | 1,392 | $57K |
| 64415 | <1% | 793 | $56K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,094 | $55K |
| 93227 | <1% | 2,506 | $55K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 178 | $53K |
| 99417 | Prolong home eval add 15m | <1% | 1,941 | $53K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,029 | $52K |
| 86780 | <1% | 2,989 | $52K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,084 | $52K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,041 | $51K |
| 94726 | <1% | 4,529 | $51K | |
| 64405 | <1% | 993 | $50K | |
| 31237 | <1% | 152 | $50K | |
| 96900 | <1% | 2,808 | $50K | |
| 99243 | <1% | 385 | $49K | |
| 88188 | <1% | 856 | $49K | |
| 0012A | <1% | 1,175 | $49K | |
| 78816 | <1% | 39 | $48K | |
| 99383 | <1% | 475 | $48K | |
| 72110 | <1% | 3,321 | $48K | |
| 92060 | <1% | 833 | $48K | |
| 74019 | <1% | 3,816 | $48K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 10,510 | $46K |
| 0064A | <1% | 1,075 | $46K | |
| 93351 | <1% | 220 | $45K | |
| 93248 | <1% | 1,885 | $44K | |
| 99386 | <1% | 338 | $44K | |
| 57454 | <1% | 216 | $44K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,664 | $43K |
| 99051 | <1% | 19,680 | $43K | |
| 0072A | <1% | 962 | $43K | |
| 80061 | Lipid panel | <1% | 2,880 | $43K |
| 71271 | <1% | 934 | $43K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 221 | $42K |
| 93798 | <1% | 1,816 | $42K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 168 | $42K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,112 | $41K |
| 93018 | <1% | 3,273 | $41K | |
| 77334 | <1% | 404 | $41K | |
| 0001A | <1% | 1,007 | $41K | |
| 84166 | <1% | 2,571 | $40K | |
| 94729 | <1% | 4,719 | $40K | |
| 93458 | <1% | 123 | $40K | |
| 92020 | <1% | 1,710 | $40K | |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | <1% | 329 | $40K |
| 70491 | <1% | 573 | $39K | |
| 95024 | <1% | 557 | $38K | |
| 90474 | <1% | 2,957 | $36K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 180 | $36K |
| 51798 | <1% | 3,280 | $36K | |
| 59410 | <1% | 25 | $36K | |
| 72156 | <1% | 236 | $36K | |
| 90750 | <1% | 185 | $35K | |
| 73564 | <1% | 1,429 | $35K | |
| 76604 | <1% | 1,385 | $34K | |
| 95806 | <1% | 314 | $32K | |
| 99382 | <1% | 332 | $32K | |
| 94060 | <1% | 2,574 | $32K | |
| 72157 | <1% | 191 | $31K | |
| 72040 | <1% | 1,817 | $31K | |
| 73140 | <1% | 1,577 | $31K | |
| 76882 | <1% | 732 | $31K | |
| 0011A | <1% | 887 | $30K | |
| 73590 | <1% | 2,205 | $30K | |
| 72146 | <1% | 269 | $30K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 2,069 | $30K |
| 90461 | <1% | 39,184 | $29K | |
| 93244 | <1% | 1,299 | $28K | |
| 69210 | <1% | 1,181 | $28K | |
| 87490 | <1% | 1,307 | $27K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 98 | $27K |
| 95028 | <1% | 143 | $27K | |
| 90961 | <1% | 113 | $27K | |
| 76870 | <1% | 765 | $27K | |
| 92082 | <1% | 780 | $27K | |
| 90670 | <1% | 17,015 | $26K | |
| 88313 | <1% | 1,898 | $25K | |
| 88173 | <1% | 283 | $25K | |
| 93975 | <1% | 376 | $25K | |
| 77080 | <1% | 3,367 | $24K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 202 | $24K |
| 95913 | <1% | 124 | $24K | |
| 77072 | <1% | 1,957 | $23K | |
| 93294 | <1% | 1,302 | $23K | |
| 95811 | <1% | 61 | $23K | |
| 0742T | <1% | 533 | $23K | |
| 0002A | <1% | 524 | $23K | |
| 99471 | <1% | 25 | $23K | |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | <1% | 1,528 | $23K |
| 99173 | <1% | 5,560 | $23K | |
| 99201 | <1% | 473 | $22K | |
| 99384 | <1% | 182 | $22K | |
| 73080 | <1% | 1,366 | $22K | |
| 96112 | <1% | 233 | $21K | |
| 94664 | <1% | 1,566 | $21K | |
| 81025 | <1% | 1,933 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 613 | $20K |
| 99236 | Prolong inpt eval add15 m | <1% | 95 | $20K |
| 93228 | <1% | 1,046 | $20K | |
| 72158 | <1% | 138 | $20K | |
| 88312 | <1% | 543 | $20K | |
| 92285 | <1% | 1,390 | $20K | |
| 70496 | <1% | 263 | $20K | |
| 77300 | <1% | 175 | $19K | |
| 77073 | <1% | 739 | $19K | |
| 64413 | <1% | 178 | $19K | |
| 96151 | <1% | 704 | $18K | |
| 81003 | <1% | 6,599 | $18K | |
| 64999 | <1% | 140 | $18K | |
| 92002 | <1% | 271 | $18K | |
| 52000 | <1% | 105 | $18K | |
| 95251 | <1% | 593 | $17K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 3,276 | $17K |
| 92136 | <1% | 513 | $17K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,407 | $16K |
| 99421 | <1% | 1,254 | $16K | |
| 86803 | <1% | 1,056 | $16K | |
| 99152 | <1% | 1,130 | $15K | |
| 77263 | <1% | 99 | $15K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 842 | $15K |
| 64447 | <1% | 331 | $15K | |
| 74178 | <1% | 163 | $15K | |
| 90656 | <1% | 1,839 | $14K | |
| 91200 | <1% | 1,176 | $14K | |
| 97014 | <1% | 1,323 | $14K | |
| 90837 | Psychotherapy session, about an hour | <1% | 99 | $14K |
| 29876 | <1% | 28 | $13K | |
| 00920 | <1% | 52 | $13K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,414 | $13K |
| 70498 | <1% | 187 | $12K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 15 | $12K |
| 99447 | <1% | 455 | $12K | |
| 82330 | <1% | 871 | $12K | |
| 72081 | <1% | 323 | $12K | |
| 19083 | <1% | 83 | $12K | |
| 97165 | <1% | 158 | $12K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 41 | $12K |
| 90732 | <1% | 77 | $11K | |
| 87522 | Neg quan hep c or qual rna | <1% | 224 | $11K |
| 99476 | <1% | 29 | $11K | |
| 73090 | <1% | 766 | $11K | |
| 82375 | <1% | 869 | $11K | |
| 85610 | <1% | 2,518 | $11K | |
| 82948 | <1% | 2,334 | $10K | |
| 93990 | <1% | 628 | $10K | |
| 84484 | <1% | 820 | $10K | |
| 94618 | <1% | 624 | $10K | |
| 83605 | <1% | 866 | $10K | |
| 95714 | <1% | 50 | $10K | |
| 01810 | <1% | 98 | $10K | |
| 99253 | <1% | 90 | $10K | |
| 99188 | <1% | 681 | $10K | |
| 99255 | <1% | 45 | $10K | |
| 01480 | <1% | 43 | $10K | |
| 73522 | <1% | 463 | $10K | |
| 95700 | <1% | 43 | $9K | |
| 99454 | <1% | 226 | $9K | |
| 74240 | <1% | 227 | $9K | |
| 11056 | <1% | 211 | $9K | |
| 36620 | <1% | 202 | $9K | |
| 70547 | <1% | 190 | $9K | |
| 17110 | <1% | 83 | $9K | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 653 | $9K |
| 90691 | <1% | 70 | $8K | |
| 86850 | <1% | 652 | $8K | |
| 78832 | <1% | 13 | $8K | |
| 74230 | <1% | 323 | $8K | |
| 90937 | <1% | 116 | $8K | |
| 92587 | <1% | 399 | $8K | |
| 74328 | <1% | 264 | $8K | |
| 95018 | <1% | 232 | $8K | |
| 72195 | <1% | 55 | $8K | |
| 62323 | <1% | 76 | $8K | |
| 93229 | <1% | 29 | $8K | |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | <1% | 416 | $7K |
| 72070 | <1% | 528 | $7K | |
| 88300 | <1% | 1,521 | $7K | |
| 73521 | <1% | 490 | $7K | |
| 76775 | <1% | 231 | $7K | |
| 17000 | <1% | 96 | $7K | |
| 83050 | <1% | 868 | $7K | |
| 92235 | <1% | 105 | $7K | |
| 72197 | <1% | 27 | $7K | |
| 00145 | <1% | 24 | $7K | |
| 82010 | <1% | 1,102 | $7K | |
| 83735 | <1% | 1,038 | $7K | |
| 86592 | <1% | 1,630 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 228 | $7K |
| 82800 | <1% | 660 | $7K | |
| 01402 | <1% | 28 | $7K | |
| 92579 | <1% | 150 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 269 | $7K |
| 58301 | <1% | 51 | $7K | |
| 90962 | <1% | 38 | $6K | |
| 81001 | <1% | 1,637 | $6K | |
| 85018 | <1% | 2,106 | $6K | |
| 99100 | <1% | 96 | $6K | |
| 98968 | <1% | 156 | $6K | |
| 90662 | <1% | 326 | $6K | |
| 85730 | <1% | 993 | $6K | |
| 72050 | <1% | 379 | $6K | |
| 95180 | <1% | 43 | $6K | |
| 82550 | <1% | 841 | $6K | |
| 72131 | <1% | 130 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 211 | $6K |
| 01400 | <1% | 20 | $6K | |
| 00400 | <1% | 22 | $5K | |
| 77301 | <1% | 13 | $5K | |
| 86769 | <1% | 185 | $5K | |
| 64483 | <1% | 48 | $5K | |
| 00402 | <1% | 12 | $5K | |
| 99401 | <1% | 413 | $5K | |
| 87631 | <1% | 34 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 131 | $5K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 42 | $5K |
| 86900 | <1% | 678 | $5K | |
| 99448 | <1% | 112 | $5K | |
| 90620 | <1% | 41 | $5K | |
| 83690 | <1% | 720 | $5K | |
| 95873 | <1% | 111 | $5K | |
| 84295 | <1% | 959 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 579 | $5K |
| 31500 | <1% | 31 | $5K | |
| 58300 | <1% | 27 | $5K | |
| 95885 | <1% | 160 | $4K | |
| 20526 | <1% | 55 | $4K | |
| 73720 | <1% | 13 | $4K | |
| 90836 | <1% | 47 | $4K | |
| 01922 | <1% | 12 | $4K | |
| 43235 | <1% | 29 | $4K | |
| 97010 | <1% | 3,095 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 89 | $4K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 475 | $4K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 40 | $4K |
| 76937 | <1% | 384 | $4K | |
| 88365 | <1% | 108 | $4K | |
| 82947 | <1% | 970 | $4K | |
| 90734 | <1% | 1,370 | $4K | |
| 78264 | <1% | 59 | $4K | |
| 86901 | <1% | 677 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 12 | $4K |
| 00140 | <1% | 24 | $4K | |
| 77049 | <1% | 13 | $4K | |
| 84132 | <1% | 754 | $4K | |
| 28470 | <1% | 13 | $4K | |
| 43264 | <1% | 13 | $4K | |
| 92588 | <1% | 120 | $4K | |
| 77085 | <1% | 368 | $4K | |
| 86593 | <1% | 780 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 87 | $3K |
| 73552 | <1% | 213 | $3K | |
| 99406 | <1% | 181 | $3K | |
| 82803 | <1% | 109 | $3K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 163 | $3K |
| 87563 | <1% | 84 | $3K | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 526 | $3K |
| S9441 | Asthma education, non-physician provider, per session | <1% | 390 | $3K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 93 | $3K |
| 99457 | <1% | 155 | $3K | |
| 88360 | <1% | 19 | $3K | |
| 96150 | <1% | 87 | $3K | |
| 95886 | <1% | 31 | $3K | |
| 76886 | <1% | 88 | $3K | |
| 0124A | <1% | 130 | $3K | |
| 62328 | <1% | 24 | $3K | |
| 36556 | <1% | 19 | $3K | |
| 67840 | <1% | 12 | $3K | |
| 73718 | <1% | 28 | $3K | |
| 36569 | <1% | 26 | $3K | |
| 51728 | <1% | 12 | $3K | |
| 98967 | <1% | 138 | $3K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 13 | $3K |
| 00813 | <1% | 21 | $3K | |
| 86580 | <1% | 94 | $3K | |
| 87340 | <1% | 241 | $2K | |
| 86706 | <1% | 228 | $2K | |
| 73700 | <1% | 53 | $2K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 119 | $2K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 56 | $2K |
| 64445 | <1% | 37 | $2K | |
| 19281 | <1% | 12 | $2K | |
| 0298T | <1% | 173 | $2K | |
| 00300 | <1% | 12 | $2K | |
| 83880 | <1% | 53 | $2K | |
| 76514 | <1% | 470 | $2K | |
| 20553 | <1% | 100 | $2K | |
| 93304 | <1% | 52 | $2K | |
| 57456 | <1% | 13 | $2K | |
| 70360 | <1% | 206 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 108 | $2K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 32 | $2K |
| 90716 | <1% | 210 | $2K | |
| 64644 | <1% | 13 | $2K | |
| 84403 | <1% | 68 | $2K | |
| 92555 | <1% | 90 | $2K | |
| 84100 | <1% | 381 | $2K | |
| 0004A | <1% | 72 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 115 | $2K |
| 88302 | <1% | 166 | $2K | |
| 96401 | <1% | 28 | $2K | |
| 74221 | <1% | 58 | $2K | |
| 11982 | <1% | 12 | $2K | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | <1% | 54 | $2K |
| 72170 | <1% | 115 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 231 | $1K |
| 29580 | <1% | 23 | $1K | |
| 93985 | <1% | 43 | $1K | |
| 95800 | <1% | 37 | $1K | |
| 97116 | <1% | 52 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 898 | $1K |
| 51797 | <1% | 12 | $1K | |
| 92025 | <1% | 65 | $1K | |
| 91322 | <1% | 62 | $1K | |
| 90680 | <1% | 8,458 | $1K | |
| 29075 | <1% | 13 | $1K | |
| 76981 | <1% | 32 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 778 | $1K |
| 78708 | <1% | 14 | $1K | |
| 0134A | <1% | 48 | $1K | |
| 97162 | <1% | 12 | $1K | |
| 96168 | <1% | 33 | $1K | |
| 11104 | <1% | 14 | $1K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 14 | $1K |
| 93321 | <1% | 151 | $1K | |
| 92201 | <1% | 44 | $1K | |
| 97032 | <1% | 106 | $1K | |
| 98960 | <1% | 917 | $1K | |
| 90633 | <1% | 4,493 | $980.82 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 75 | $953.03 |
| 99497 | <1% | 37 | $866.78 | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 12 | $864.50 |
| 0003A | <1% | 18 | $824.94 | |
| 95807 | <1% | 12 | $823.96 | |
| 93978 | <1% | 27 | $821.06 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,375 | $805.29 |
| 58100 | <1% | 12 | $804.93 | |
| 71101 | <1% | 39 | $796.94 | |
| 85097 | <1% | 15 | $755.35 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 18 | $744.81 |
| 3078F | <1% | 9,554 | $743.23 | |
| 93272 | <1% | 38 | $702.56 | |
| 84402 | <1% | 25 | $700.50 | |
| 11730 | <1% | 13 | $695.20 | |
| 99140 | <1% | 77 | $640.00 | |
| 86708 | <1% | 56 | $633.91 | |
| 90480 | <1% | 24 | $632.63 | |
| 93246 | <1% | 64 | $625.35 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 24 | $609.27 |
| G0008 | Administration of influenza virus vaccine | <1% | 328 | $598.55 |
| 73100 | <1% | 15 | $597.85 | |
| 99235 | <1% | 13 | $576.82 | |
| 3074F | <1% | 6,827 | $554.82 | |
| 76377 | <1% | 15 | $548.00 | |
| 93922 | <1% | 26 | $546.44 | |
| 92550 | <1% | 27 | $541.79 | |
| 76946 | <1% | 12 | $503.38 | |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | <1% | 40 | $500.88 |
| 97035 | <1% | 60 | $486.70 | |
| 72083 | <1% | 27 | $486.68 | |
| 99446 | <1% | 23 | $471.29 | |
| 36410 | <1% | 250 | $455.06 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 15 | $441.47 |
| 11055 | <1% | 12 | $423.11 | |
| 76776 | <1% | 16 | $389.86 | |
| 84703 | <1% | 57 | $381.60 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 14 | $374.85 |
| 82150 | <1% | 68 | $370.60 | |
| 97597 | <1% | 19 | $369.30 | |
| 92225 | <1% | 27 | $367.11 | |
| 93986 | <1% | 12 | $366.26 | |
| 86704 | <1% | 28 | $364.83 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 293 | $362.55 |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 13 | $349.92 |
| 90698 | <1% | 2,666 | $335.97 | |
| 90707 | <1% | 206 | $327.09 | |
| 51784 | <1% | 12 | $316.82 | |
| 90697 | <1% | 995 | $315.37 | |
| 73060 | <1% | 27 | $287.27 | |
| 72084 | <1% | 12 | $283.62 | |
| Q4032 | Cast supplies, long leg cast, pediatric (0-10 years), fiberglass | <1% | 13 | $276.82 |
| 92558 | <1% | 31 | $257.76 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 12 | $252.00 |
| 90723 | <1% | 1,942 | $234.20 | |
| 20552 | <1% | 12 | $226.08 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 20 | $220.93 |
| 90863 | <1% | 12 | $213.80 | |
| 88311 | <1% | 14 | $209.13 | |
| 82657 | <1% | 13 | $207.87 | |
| 76098 | <1% | 14 | $202.78 | |
| 80361 | <1% | 12 | $202.75 | |
| 80076 | <1% | 12 | $191.24 | |
| 93793 | <1% | 18 | $182.48 | |
| 90785 | <1% | 12 | $177.82 | |
| 90744 | <1% | 378 | $175.22 | |
| 51741 | <1% | 28 | $144.74 | |
| 93280 | <1% | 12 | $138.17 | |
| 95012 | <1% | 181 | $130.04 | |
| 84439 | <1% | 13 | $128.96 | |
| 77081 | <1% | 13 | $125.68 | |
| 84702 | <1% | 13 | $115.92 | |
| 17003 | <1% | 16 | $113.36 | |
| 82570 | <1% | 24 | $103.17 | |
| 85027 | <1% | 24 | $96.58 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 21 | $90.00 |
| 3079F | <1% | 1,805 | $63.53 | |
| 82962 | <1% | 24 | $63.16 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 12 | $56.93 |
| J3490 | Unclassified drugs | <1% | 126 | $55.99 |
| 85007 | <1% | 24 | $51.26 | |
| 96160 | <1% | 27 | $50.70 | |
| 90688 | <1% | 66 | $48.24 | |
| 90648 | <1% | 1,913 | $47.11 | |
| 80365 | <1% | 13 | $35.00 | |
| 90647 | <1% | 1,598 | $32.86 | |
| 90674 | <1% | 13 | $29.23 | |
| 3075F | <1% | 709 | $22.80 | |
| 90685 | <1% | 658 | $17.85 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 43 | $16.65 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 14 | $15.99 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 74 | $15.92 |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 12 | $12.46 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 80 | $6.40 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 201 | $6.13 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 16 | $5.94 |
| 3077F | <1% | 431 | $5.54 | |
| 91312 | <1% | 370 | $3.93 | |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 19 | $3.02 |
| Q4049 | Finger splint, static | <1% | 13 | $3.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $0.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 121 | $0.72 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 290 | $0.68 |
| 0503F | <1% | 68 | $0.38 | |
| 91313 | <1% | 93 | $0.11 | |
| 99080 | 0% | 13,139 | $0.00 | |
| 90710 | 0% | 744 | $0.00 | |
| 90681 | 0% | 31 | $0.00 | |
| 99499 | 0% | 1,891 | $0.00 | |
| 90672 | 0% | 29 | $0.00 | |
| 90700 | 0% | 140 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 119 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 71 | $0.00 |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 13 | $0.00 |
| 90687 | 0% | 27 | $0.00 | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | 0% | 14 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 167 | $0.00 |
| 90696 | 0% | 257 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 17 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 84 | $0.00 |
| 99024 | 0% | 14 | $0.00 | |
| 36000 | 0% | 13 | $0.00 | |
| 36416 | 0% | 36 | $0.00 | |
| 1005F | 0% | 55 | $0.00 | |
| 76883 | 0% | 12 | $0.00 | |
| J2357 | Injection, omalizumab, 5 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPREOLO, JOHN (SR DIRECTOR PROVIDER CREDENTIALING)
Parent organizationMONTEFIORE MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Montefiore New Rochelle Hospital | Yonkers, NY | $3.05M |
| Montefiore Mount Vernon Hospital | Mount Vernon, NY | $560K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.